Mike Klein

CEO at Genomenon

With over 25 years of developing, building and growing 4 different high tech companies, Mike raised over $50M in capital and had several successful investor exits.

Links

Org chart

Peers

Reports

Mark J. Kiel

CSO & Co-Founder

Dave Anstey

VP, Pharma Business Development

Sean Kearney

CFO

Sam Globus

VP, Operations

Teams

CEO and Executive Team

3 members

Leadership Team

5 members

Timeline

CEO
Current role

View in org chart